One More Step…

Opening Recap Market Pulse: Equities drifted as bond yields held steady and the dollar didn’t budge, with traders on edge before another round of tariff

Company Overview Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharmaceutical company focused on neuroscience, recently thrust into the spotlight after a major late-stage trial setback.

Daily Financial Update Good Monday morning—let’s cut through the noise and get you up to speed on what really matters. Opening Recap Market Pulse: AI